ask="55.03"
ask_size="200"
average_daily_volume="508552"
bid="51.00"
bid_size="200"
book_value="11.13"
change="-0.37"
change_from_200_day_moving_average="10.09"
change_from_50_day_moving_average="3.28"
change_from_52_week_high="-3.08"
change_From_52_week_low="27.09"
change_in_percent="-0.69%"
close="53.37"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.20"
ebitda="-132.17M"
eps_estimate_current_year="-4.36"
eps_estimate_next_quarter="-1.25"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="32759000"
high="54.04"
high_52_weeks="56.45"
last_trade_date="1/9/2017"
last_trade_price="53.37"
last_trade_size="23659"
last_trade_time="4:00pm"
low="52.64"
low_52_weeks="26.28"
market_capitalization="1.98B"
moving_average_200_day="43.28"
moving_average_50_day="50.09"
name="Sage Therapeutics
Inc."
notes="N/A"
one_year_target_price="75.09"
open="54.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+23.31%"
percent_change_from_50_day_moving_average="+6.54%"
percent_change_from_52_week_high="-5.46%"
percent_change_from_52_week_low="+103.08%"
previous_close="53.74"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.83"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37167000"
short_ratio="6.49"
stock_exchange="NGM"
symbol="SAGE"
volume="361011"
weeks_range_52="26.28 - 56.45"
